| 2024-04 |
Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease |
European Journal of Gastroenterology and Hepatology
|
| 2024-02 |
Causal Analyses of Statin to Prevent Liver Disease Progression: A Nationwide Study Using Superlearning Targeted Maximum Likelihood Estimation |
약 학 회 지
|
| 2023-12 |
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy |
Journal of the Formosan Medical Association = Taiwan yi zhi
|
| 2023-12 |
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study |
Hepatology
|
| 2023-11 |
Association of Alcohol Consumption With Liver Cancer and All-Cause Mortality in Chronic Hepatitis B Patients Without Cirrhosis |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2023-11 |
Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma |
Cell Communication and Signaling
|
| 2023-11 |
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis |
Alimentary Pharmacology and Therapeutics
|
| 2023-09 |
MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
How to deliver palliative care for patients with management in decompensated cirrhosis |
HEPATOBILIARY SURGERY AND NUTRITION
|
| 2023-08 |
Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus‐related liver cirrhosis |
Journal of Gastroenterology and Hepatology
|
| 2023-08 |
A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B |
Liver international : official journal of the International Association for the Study of the Liver
|
| 2023-08 |
ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis |
Clinical Gastroenterology and Hepatology
|
| 2023-07 |
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD |
Alimentary Pharmacology and Therapeutics
|
| 2023-06 |
Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study |
American Journal of Gastroenterology
|
| 2023-05 |
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease |
Gut and Liver
|
| 2023-05 |
Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis |
Hepatology
|
| 2023-04 |
Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma |
European Journal of Clinical Investigation
|
| 2023-04 |
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study |
Clinical and Molecular Hepatology
|
| 2023-03 |
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease |
Liver International
|
| 2023-02 |
Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment |
Cancer Medicine
|
| 2023-02 |
Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma |
European Journal of Gastroenterology and Hepatology
|
| 2023-01 |
The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA |
Journal of Gastroenterology and Hepatology
|
| 2023-01 |
Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study |
European Journal of Internal Medicine
|
| 2023-01 |
Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis |
DIAGNOSTICS
|
| 2022-12 |
New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease |
Clinical and Translational Gastroenterology
|
| 2022-12 |
Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study |
Hepatology Research
|
| 2022-12 |
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD |
Journal of Hepatology
|
| 2022-11 |
How to Optimize the Care Cascade of Hepatitis C Virus Infection |
Gut and liver
|
| 2022-11 |
Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database |
Journal of Gastroenterology and Hepatology (Australia)
|
| 2022-10 |
Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study |
CANCERS
|
| 2022-10 |
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants |
Gastroenterology
|
| 2022-09 |
Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis |
International Journal of Biological Sciences
|
| 2022-09 |
Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study |
Hepatology Communications
|
| 2022-09 |
The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials |
OBESITY REVIEWS
|
| 2022-08 |
Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model |
Gastroenterology Report
|
| 2022-08 |
Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk |
LIVER INTERNATIONAL
|
| 2022-08 |
Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-07 |
Evidence of nonsurgical treatment for polycystic liver disease |
THERAPEUTIC ADVANCES IN CHRONIC DISEASE
|
| 2022-07 |
Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B |
Digestive Diseases and Sciences
|
| 2022-07 |
Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2022-06 |
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus A Reconstructed Individual Patient Data Meta-analysis |
JAMA Network Open
|
| 2022-05 |
Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone |
Clinical Pharmacology in Drug Development
|
| 2022-05 |
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis |
Cancers
|
| 2022-05 |
Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2022-04 |
Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria |
Frontiers in Medicine
|
| 2022-04 |
Cost-effectiveness of chronic hepatitis C screening and treatment |
Clinical and molecular hepatology
|
| 2022-04 |
Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-04 |
Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL |
HEPATOLOGY INTERNATIONAL
|
| 2022-04 |
Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study |
JOURNAL OF VIRAL HEPATITIS
|
| 2022-03 |
Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease |
Gut and Liver
|
| 2022-03 |
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study |
Cancers
|
| 2022-03 |
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease |
GUT AND LIVER
|
| 2022-03 |
Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination |
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
|
| 2022-02 |
Predictors of Sarcopenia in an Obese Asian Population |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
|
| 2022-02 |
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study |
Cancers
|
| 2022-02 |
Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis |
Diagnostics
|
| 2022-02 |
Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA ,2,000 IU/mL |
AMERICAN JOURNAL OF GASTROENTEROLOGY
|
| 2022-01 |
Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2022-01 |
Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients |
Cancers
|
| 2022-01 |
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization |
Cancers
|
| 2021-12 |
Pharmacological inhibition of sonic hedgehog signaling suppresses tumor development in a murine model of intrahepatic cholangiocarcinoma |
International Journal of Molecular Sciences
|
| 2021-12 |
Novel liver stiffness-based nomogram for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection initiating antiviral therapy |
Cancers
|
| 2021-11 |
No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-11 |
A qualitative study of self-management experiences in people with non-alcoholic fatty liver disease |
Nursing Open
|
| 2021-10 |
Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma |
AMERICAN JOURNAL OF CANCER RESEARCH
|
| 2021-10 |
Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease |
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
|
| 2021-10 |
Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-10 |
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B |
HEPATOLOGY INTERNATIONAL
|
| 2021-09 |
Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-09 |
Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease |
Cancers
|
| 2021-09 |
Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis B |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-08 |
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy |
HEPATOLOGY INTERNATIONAL
|
| 2021-07 |
The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus & ndash;related hepatocellular carcinoma |
EUROPEAN JOURNAL OF INTERNAL MEDICINE
|
| 2021-07 |
Pharmacokinetics and safety of evogliptin in hepatically impaired patients |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
|
| 2021-07 |
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study |
DIGESTIVE DISEASES AND SCIENCES
|
| 2021-06 |
Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-06 |
Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B |
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
|
| 2021-06 |
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer |
Translational Oncology
|
| 2021-06 |
External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antivirals |
JOURNAL OF VIRAL HEPATITIS
|
| 2021-05 |
Impact of COVID-19 on Gastroenterology Fellowship Training |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
|
| 2021-05 |
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2021-05 |
Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma |
GUT AND LIVER
|
| 2021-05 |
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B |
Journal of Hepatocellular Carcinoma
|
| 2021-04 |
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
| 2021-04 |
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients |
JOURNAL OF KOREAN MEDICAL SCIENCE
|
| 2021-04 |
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B |
Clinical and molecular hepatology
|
| 2021-04 |
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B |
HEPATOLOGY RESEARCH
|